|Application:||Gene expression microarray analysis|
|Number of samples:||14|
|Release date:||Nov 5 2013|
|Last update date:||Apr 5 2017|
|Diseases:||Anemia, Myelodysplastic Syndromes, Anemia, Diamond-Blackfan|
|Dataset link||5q- Myelodysplastic Syndrome Masquerading as Diamond Blackfan Anemia|
Samples were analyzed on Illumina HumanOmni1_Quad, HumanOmniExpress, or HumanOmniExpressExome Genotyping bead arrays; 1 patient was available for longitudinal study including assessment of mosaicism in lymphoid and myeloid-enriched cell populations before treatement with lenolidamide. Similar studies were performed while on lenoldamide therapy in peripheral blood at 3 months and in bone marrow at 20 months of treatment. One patient with mosaic deletion of 5q was available for longitudinal study including assessment of gene expression in bone marrow before and during treatment with lenalidomide.
Jason Eli Farrar